ITMCTR2100005345尚未招募1 期
Efficacy and safety of Simiao pill in the treatment of hyperuricemia
Southern Medical University0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 性别
- All
入选标准
- •1. In accordance with the diagnostic criteria of hyperuricemia, or conform to the diagnostic criteria of people of good health status;
- •2. Aged 18 to 30 years male and female;
- •3. The subjects of hyperuricemia conforms to the clinical syndrome diagnosis standard of damp heat syndrome in traditional Chinese medicine;
- •4. The subjects are informed and voluntarily signed the informed consent.
排除标准
- •1. Living with a serious adverse lifestyle;
- •2. With any infection in recent four weeks;
- •3. Pregnant or lactating women, or people who are allergic to the test drug;
- •4. Subjects who are taking part in other drugs clinical trials;
- •5. Volunteers whom researchers believe not suitable for the clinical trail with other reasons;
- •6. Hereditary disease;
- •7. Use of antibiotics, probiotics, prebiotics, or synbiotics in two months before collection of the fecal sample.
研究者
相似试验
已完成
1 期
Siddha medicine for HIVCTRI/2008/091/000021daykumar Ranga, JNCASR, Bangalore
已完成
3 期
Comparison of the Effects of Oral Sirolimus and Oral Cyclosporine on the Thrombocytopenic Chronic PurpuraImmune thrombocytopenic purpuraIRCT20180501039499N1Arak University of Medical Sciences60
已完成
不适用
Clinical study on efficacy and safety of sirolimus against epileptic seizures of focal cortical dysplasia type IIPatients with epilepsy with focal cortical dysplasia type 2JPRN-UMIN000030962Hokkaido University Hospital2
进行中（未招募）
不适用
Study on the effectiveness and safety of the treatment of hyponatremia due to inappropriate secretion of antidiuretic hormone (SIADH) with Tolvaptan vs fluid restriction in patients affected by pituitary disorders.EUCTR2012-004071-39-ITFONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO
招募中
不适用
The pharmacokinetic analysis and safety of sirolimus treatment for pediatric patients with intractable vascular anomaliesIntractable vascular anomaliesJPRN-UMIN000029175Gifu University20